Annual CAPEX
$609.00 K
-$186.00 K-23.40%
31 December 2023
Summary:
Protagonist Therapeutics annual capital expenditures is currently $609.00 thousand, with the most recent change of -$186.00 thousand (-23.40%) on 31 December 2023. During the last 3 years, it has risen by +$138.00 thousand (+29.30%). PTGX annual CAPEX is now -44.69% below its all-time high of $1.10 million, reached on 31 December 2021.PTGX CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$775.00 K
+$747.00 K+2667.86%
30 September 2024
Summary:
Protagonist Therapeutics quarterly capital expenditures is currently $775.00 thousand, with the most recent change of +$747.00 thousand (+2667.86%) on 30 September 2024. Over the past year, it has increased by +$371.00 thousand (+91.83%). PTGX quarterly CAPEX is now -13.12% below its all-time high of $892.00 thousand, reached on 30 June 2019.PTGX Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$1.06 M
+$371.00 K+53.54%
30 September 2024
Summary:
Protagonist Therapeutics TTM capital expenditures is currently $1.06 million, with the most recent change of +$371.00 thousand (+53.54%) on 30 September 2024. Over the past year, it has increased by +$404.00 thousand (+61.21%). PTGX TTM CAPEX is now -16.09% below its all-time high of $1.27 million, reached on 30 June 2019.PTGX TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PTGX CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -23.4% | +91.8% | +61.2% |
| 3 y3 years | +29.3% | +192.4% | +3.3% |
| 5 y5 years | +25.3% | +350.8% | +31.2% |
PTGX CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -44.7% | +29.3% | at high | +7650.0% | -13.8% | +154.6% |
| 5 y | 5 years | -44.7% | +29.3% | at high | +350.8% | -13.8% | +491.1% |
| alltime | all time | -44.7% | +29.3% | -13.1% | +350.8% | -16.1% | +491.1% |
Protagonist Therapeutics CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $775.00 K(+2667.9%) | $1.06 M(+53.5%) |
| June 2024 | - | $28.00 K(-88.4%) | $693.00 K(-17.6%) |
| Mar 2024 | - | $242.00 K(+1173.7%) | $841.00 K(+38.1%) |
| Dec 2023 | $609.00 K(-23.4%) | $19.00 K(-95.3%) | $609.00 K(-7.7%) |
| Sept 2023 | - | $404.00 K(+129.5%) | $660.00 K(+57.9%) |
| June 2023 | - | $176.00 K(+1660.0%) | $418.00 K(-21.4%) |
| Mar 2023 | - | $10.00 K(-85.7%) | $532.00 K(-33.1%) |
| Dec 2022 | $795.00 K(-27.8%) | $70.00 K(-56.8%) | $795.00 K(-13.7%) |
| Sept 2022 | - | $162.00 K(-44.1%) | $921.00 K(-10.1%) |
| June 2022 | - | $290.00 K(+6.2%) | $1.02 M(-17.0%) |
| Mar 2022 | - | $273.00 K(+39.3%) | $1.23 M(+12.1%) |
| Dec 2021 | $1.10 M | $196.00 K(-26.0%) | $1.10 M(+6.9%) |
| Sept 2021 | - | $265.00 K(-47.0%) | $1.03 M(+22.6%) |
| June 2021 | - | $500.00 K(+257.1%) | $840.00 K(+77.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $140.00 K(+12.0%) | $473.00 K(+0.4%) |
| Dec 2020 | $471.00 K(-51.3%) | $125.00 K(+66.7%) | $471.00 K(-16.5%) |
| Sept 2020 | - | $75.00 K(-43.6%) | $564.00 K(+213.3%) |
| June 2020 | - | $133.00 K(-3.6%) | $180.00 K(-80.8%) |
| Mar 2020 | - | $138.00 K(-36.7%) | $939.00 K(-2.9%) |
| Dec 2019 | $967.00 K(+99.0%) | $218.00 K(-170.6%) | $967.00 K(+19.2%) |
| Sept 2019 | - | -$309.00 K(-134.6%) | $811.00 K(-36.0%) |
| June 2019 | - | $892.00 K(+437.3%) | $1.27 M(+185.6%) |
| Mar 2019 | - | $166.00 K(+167.7%) | $444.00 K(-8.6%) |
| Dec 2018 | $486.00 K(-27.0%) | $62.00 K(-58.1%) | $486.00 K(+1.3%) |
| Sept 2018 | - | $148.00 K(+117.6%) | $480.00 K(-8.0%) |
| June 2018 | - | $68.00 K(-67.3%) | $522.00 K(+15.0%) |
| Mar 2018 | - | $208.00 K(+271.4%) | $454.00 K(+84.6%) |
| Dec 2017 | $666.00 K | $56.00 K(-70.5%) | $246.00 K(+29.5%) |
| Sept 2017 | - | $190.00 K | $190.00 K |
FAQ
- What is Protagonist Therapeutics annual capital expenditures?
- What is the all time high annual CAPEX for Protagonist Therapeutics?
- What is Protagonist Therapeutics annual CAPEX year-on-year change?
- What is Protagonist Therapeutics quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Protagonist Therapeutics?
- What is Protagonist Therapeutics quarterly CAPEX year-on-year change?
- What is Protagonist Therapeutics TTM capital expenditures?
- What is the all time high TTM CAPEX for Protagonist Therapeutics?
- What is Protagonist Therapeutics TTM CAPEX year-on-year change?
What is Protagonist Therapeutics annual capital expenditures?
The current annual CAPEX of PTGX is $609.00 K
What is the all time high annual CAPEX for Protagonist Therapeutics?
Protagonist Therapeutics all-time high annual capital expenditures is $1.10 M
What is Protagonist Therapeutics annual CAPEX year-on-year change?
Over the past year, PTGX annual capital expenditures has changed by -$186.00 K (-23.40%)
What is Protagonist Therapeutics quarterly capital expenditures?
The current quarterly CAPEX of PTGX is $775.00 K
What is the all time high quarterly CAPEX for Protagonist Therapeutics?
Protagonist Therapeutics all-time high quarterly capital expenditures is $892.00 K
What is Protagonist Therapeutics quarterly CAPEX year-on-year change?
Over the past year, PTGX quarterly capital expenditures has changed by +$371.00 K (+91.83%)
What is Protagonist Therapeutics TTM capital expenditures?
The current TTM CAPEX of PTGX is $1.06 M
What is the all time high TTM CAPEX for Protagonist Therapeutics?
Protagonist Therapeutics all-time high TTM capital expenditures is $1.27 M
What is Protagonist Therapeutics TTM CAPEX year-on-year change?
Over the past year, PTGX TTM capital expenditures has changed by +$404.00 K (+61.21%)